Answers are grounded in this paper and cite their sources.
Parkinson's Disease (PD) is a neurodegenerative condition that results in the death of dopamine-producing neurons that mainly affects the motor cortex and causes such symptoms as tremors and difficulty speaking. White early treatments for PD included ablative and stereotactic surgeries, the precise destruction of specific brain structures, these lost favor with the emergence of levodopa in the second half of the 20th century. Nevertheless, the shortcomings of this drug, such as the reduced patient sensitivity to the treatment, sparked a new interest in surgical procedures, which in turn gave rise to the Deep Brain Stimulation (DBS) technology. In this paper, we explore the history of PD treatments with a focus on DBS, as well as the developments and advancements of the technology, including innovations in software, hardware and targeting techniques. We highlight the state of the art of PD treatment and outline future possibilities in this field. • DBS provided a novel and preferred approach to managing PD to the ablative surgical techniques. • One of the most impactful hardware innovations for DBS are directional leads. • Connectomics will facilitate patient-specific targeting through neural connectivity profiles. • Adaptive DBS will enable tailored therapies.
No takes yet. Share an insight, caveat, or question.
Caiado et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: